Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review

Metabolomics, Microbiota, and In Vivo and In Vitro Biomarkers in Type 2 Severe Asthma: A Perspective Review

Precision medicine refers to the tailoring of therapeutic strategies to the individual characteristics of each patient; thus, it could be a new approach for the management of severe asthma that considers individual variability in genes, environmental exposure, and lifestyle. Precision medicine would...

Full description

Bibliographic Details
Main Authors: Cristiano Caruso, Stefania Colantuono, Alberto Nicoletti, Stefania Arasi, Davide Firinu, Antonio Gasbarrini, Angelo Coppola, Loreta Di Michele
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Metabolites
Subjects:
asthma
metabolomics
microbiota
Online Access:https://www.mdpi.com/2218-1989/11/10/647

Internet

https://www.mdpi.com/2218-1989/11/10/647

Similar Items